Clinical perspectives for the use of new hypoxic cell sensitizers
- 30 September 1982
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 8 (9) , 1491-1497
- https://doi.org/10.1016/0360-3016(82)90608-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Nitroimidazole neurotoxicity: Are mouse studies predictive?International Journal of Radiation Oncology*Biology*Physics, 1982
- Potentiation in vivo of melphalan activity by nitroimidazole compoundsInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Enhancement by electron-affinic agents of the therapeutic effects of cytotoxic agents against the KHT tumor: Structure-activity relationshipsInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamideBritish Journal of Cancer, 1981
- Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721British Journal of Cancer, 1981
- SR-2508: A 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical useInternational Journal of Radiation Oncology*Biology*Physics, 1981
- Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizerInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Structure-activity Relationships in the Development of Hypoxic Cell RadiosensitizersInternational Journal of Radiation Biology, 1979
- Hyperbaric oxygen and radiotherapy: a Medical Research Council trial in carcinoma of the cervixThe British Journal of Radiology, 1978
- Clinical Phase I Study of the Hypoxic Cell Radiosensitizer RO-07-0582, A 2-Nitroimidazole DerivativeRadiology, 1977